Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Stefan Sleijfer"'
Publikováno v:
AJOB Empirical Bioethics, 13(4), 275-286. Taylor & Francis Ltd
Background: When anti-cancer treatments have been given market authorization, but are not (yet) reimbursed within a healthcare system, physicians are confronted with ethical dilemmas. Arranging access through other channels, e.g., hospital budgets or
Autor:
Stefan Sleijfer, Melissa Vos, Hans Gelderblom, Winette T. A. van der Graaf, Saskia Litière, Nathan Touati, Florence Duffaud
Publikováno v:
Acta Oncologica, 58(6), 872-879. Informa Healthcare
Acta Oncologica, 58, 6, pp. 872-879
Acta Oncologica, 58, 872-879
Acta Oncologica, 58(6), 872-879. TAYLOR & FRANCIS LTD
Acta Oncologica, 58, 6, pp. 872-879
Acta Oncologica, 58, 872-879
Acta Oncologica, 58(6), 872-879. TAYLOR & FRANCIS LTD
Contains fulltext : 207006.pdf (Publisher’s version ) (Open Access) Background: There is an unmet need for markers predicting the outcome of patients with advanced soft tissue sarcoma (STS) treated with pazopanib. Since toxicity might be related to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040ee3db630f30ef4504209210ea98b2
https://hdl.handle.net/1887/122785
https://hdl.handle.net/1887/122785